The crosstalk between directly acting antivirals and chronic HCV patients with different stages of renal affection: A multicenter study

Bibliographic Information
Authors: El-Kassas M.; El Balakosy A.; Elbadry M.; Ahmed O.A.; Anwar C.A.; Algaber M.A.; Michael T.G.; El Tahan A.; Alborai M.; Meleak G.; Tahoon M.; Sherief A.; Raafat K.; Radwan H.; Eysa B.; Abdelaziz H.E.; Ahmed Y.; Aboul-Ezz M.; Awad A.
Journal: Clinics and Research in Hepatology and Gastroenterology
Publisher: Elsevier Masson s.r.l.
Publication Date: December 2023
Volume / Issue: Volume 47 / Issue 10
Article No.: 102232
ISSN: 22107401
DOI: 10.1016/j.clinre.2023.102232
Scopus: View on Scopus
PubMed: 37866814
Document Type: Letter
Authors and Affiliations
El-Kassas M., Endemic Medicine Department, Faculty of Medicine, Helwan University, Cairo, Egypt; El Balakosy A., Tropical Medicine Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt; Elbadry M., Endemic Medicine Department, Faculty of Medicine, Helwan University, Cairo, Egypt; Ahmed O.A., Internal Medicine Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt; Anwar C.A., Internal Medicine Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt; Algaber M.A., Gastroenterology & Hepatology, Police Authority Hospitals, Giza, Egypt; Michael T.G., Internal Medicine Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt; El Tahan A., New Cairo Viral Hepatitis Treatment Unit, New Cairo Hospital, Cairo, Egypt; Alborai M., Department of Internal Medicine, Al-Azhar University, Cairo, Egypt; Meleak G., Internal Medicine Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt; Tahoon M., Department Epidemiology and Preventive Medicine, National Liver Institute, Menoufia University, El Kom, Shebin, Egypt; Sherief A., Tropical Medicine Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt; Raafat K., Internal Medicine Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt; Radwan H., Internal Medicine Department, Medicine and Clinical Studies Research Institute, National Research Centre, Cairo, Egypt; Eysa B., Hepatology and Gastroenterology Department, National Hepatology and Tropical Medicine Research Institute, Cairo, Egypt; Abdelaziz H.E., Internal Medicine Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt; Ahmed Y., Tropical Medicine Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt; Aboul-Ezz M., Hepatology and Gastroenterology Department, Theodor Bilharz Research Institute, Cairo, Egypt; Awad A., Internal Medicine Department, Faculty of Medicine, Cairo University, Cairo, Egypt
Abstract
[No abstract available]
Keywords
Antiviral Agents; Hepacivirus; Hepatitis C; Humans; Kidney; antivirus agent; daclatasvir; ombitasvir; paritaprevir; ribavirin; simeprevir; sofosbuvir; chronic hepatitis C; chronic kidney failure; dialysis; disease classification; disease severity; drug efficacy; drug safety; estimated glomerular filtration rate; Food and Drug Administration; high risk population; human; kidney failure; kidney function; Letter; liver cirrhosis; molecular interaction; sustained virologic response; treatment response; clinical trial; complication; genetics; multicenter study
Citation Information
Scopus Citations: 0
For comprehensive information about the Theodor Bilharz Research Institute (TBRI), its institutional activities, scientific and research achievements, clinical and hospital services, and the diverse expertise offered through its 22 specialized research and clinical departments, as well as opportunities for professional training, specialized workshops, and scientific conferences, readers are invited to visit the Institute’s official website.
The website provides regularly updated information on the Institute’s latest news, research activities, scientific initiatives, clinical services, institutional programs, and academic and professional opportunities.
English Website: https://www.tbri.sci.eg/en/
Arabic Website: https://www.tbri.sci.eg/ar/
Prepared and Uploaded by:
Abdalla F. Abdalla
Electronic Portal Unit
